Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients
Public ClinicalTrials.gov record NCT01395823. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients: A Randomized Clinical Trial
Study identification
- NCT ID
- NCT01395823
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Dialysis Clinic, Inc.
- Industry
- Enrollment
- 470 participants
Conditions and interventions
Conditions
Interventions
- ergocalciferol supplementation Dietary Supplement
- placebo Other
Dietary Supplement · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2011
- Primary completion
- Mar 31, 2014
- Completion
- May 31, 2015
- Last update posted
- Mar 13, 2016
2011 – 2015
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| DCI - Redding | Redding | California | 96003 | — |
| DCI - Albany | Albany | Georgia | 31701 | — |
| DCI - Shreveport | Shreveport | Louisiana | 71103 | — |
| DCI - Boston | Boston | Massachusetts | 02111 | — |
| DCI- Columbia | Columbia | Missouri | 65201 | — |
| DCI - Kansas City | Kansas City | Missouri | 64131 | — |
| DCI- Omaha | Omaha | Nebraska | 68131 | — |
| DCI - New Brunswick | New Brunswick | New Jersey | 08903 | — |
| DCI - North Brunswick | North Brunswick | New Jersey | 08902 | — |
| DCI - Philadelphia | Philadelphia | Pennsylvania | 19129 | — |
| DCI - Knoxville | Knoxville | Tennessee | 37924 | — |
| DCI - Maryville | Maryville | Tennessee | 37804 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01395823, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 13, 2016 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01395823 live on ClinicalTrials.gov.